Pacira BioSciences (PCRX) Operating Income (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Operating Income of $6.9 million for Q1 2026, up 246.83% year-over-year from $2.0 million in Q1 2025, and up 194.96% quarter-over-quarter from $2.3 million in Q4 2025.
Pacira BioSciences (PCRX) Operating Income (2010 - 2026) Analysis & Trends
Pacira BioSciences' Operating Income history runs 17 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- In Q1 2026, Operating Income rose 246.83% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $24.1 million (up 128.49% YoY), while the FY2025 annual figure was $19.2 million, up 126.16% from the prior year.
- Operating Income for Q1 2026 stood at $6.9 million, up from $2.3 million in the prior quarter.
- The five-year high for Operating Income was $39.9 million in Q2 2023, with the low at -$139.5 million in Q3 2024.
- The 5-year median for Operating Income is $13.2 million (2024), against an average of $5.9 million.
- Peak annual rise in Operating Income reached 527.43% in 2024, while the deepest fall reached 887.35% in 2024.
- Pacira BioSciences' Operating Income stood at -$9.9 million in 2022, then jumped by 435.27% to $33.2 million in 2023, then declined by 25.52% to $24.7 million in 2024, then sank by 90.53% to $2.3 million in 2025, then surged by 194.96% to $6.9 million in 2026.
- Business Quant data shows PCRX's Operating Income at $6.9 million in Q1 2026, $2.3 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Pacira BioSciences | 943.93 Mn | 692.90 Mn | 148.24 Mn | 4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | 6.36 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 24.70 Mn |
| Sep 30, 2024 | -139.53 Mn |
| Jun 30, 2024 | 28.24 Mn |
| Mar 31, 2024 | 13.21 Mn |
| Dec 31, 2023 | 33.17 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 39.88 Mn |
| Mar 31, 2023 | -3.09 Mn |
| Dec 31, 2022 | -9.89 Mn |
| Sep 30, 2022 | 21.29 Mn |
| Jun 30, 2022 | 31.24 Mn |
| Mar 31, 2022 | 17.39 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | 31.43 Mn |